A Pain Relief Trial Utilizing the Infiltration of a Multivesicular Liposome Formulation Of BupiVacaine, EXPAREL®: A Phase 4 Health Economic Trial in Adult Patients Undergoing Ileostomy Reversal.
Phase of Trial: Phase IV
Latest Information Update: 04 Jun 2014
At a glance
- Drugs Bupivacaine (Primary) ; Ketorolac; Morphine; Nonsteroidal anti-inflammatories
- Indications Postoperative pain
- Focus Therapeutic Use
- Acronyms IMPROVE-Ileostomy Reversal
- Sponsors Pacira Pharmaceuticals
- 26 Feb 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 02 Feb 2012 Additional lead trial investigators identified as reported by ClinicalTrials.gov.
- 02 Feb 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.